Manage Your Liver
Q:

Blood Test Report :: YHK improves ALT level and liver function for hepatitis C cirrhosis patient

Blood Test Report :: YHK improves ALT level and liver function for hepatitis C cirrhosis patient
A:

Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.

 

YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to help the patient to recover and protect their liver function. [1][2][3] We can measure the level of liver cells damage by the ALT enzymes indicator found in liver function test. [4] When ALT level is high, it means that the liver cells and liver damage is more severe, on the other hand, if ALT is low and within the normal range, it means that the liver health and liver function is healthy. [5]

 

Here is a regular YHK users' (Age: 75) blood test report who has hepatitis C cirrhosis. The report shows the ALT level before and after using YHK. On 2013-08-28, the patients ALT level is 262, on the blood test shown on the 2013-09-23 the ALT level drop within normal range of 45. The ALT level has been normalised within less then 30 days. 

 

Since 2013, this patients has continue to use YHK as the main protection method for her hepatitis C and cirrhosis problem, and the patient’s ALT level has remain stable. The latest blood test report shows a ALT level of 29.

SEbloodtest1

Blood test result before and after using YHK. ALT 262 went down to 45 within 30 days.

SEbloodtest2

Recent blood test shows ALT level maintain normal at 29.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
Hepatitis CBlood Test ReportLower ALTALTASTNormal ALT level lowering ALT level
Related Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us